ArticleEMBO molecular medicine2018

Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerability.

Kenichi Iwai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.